Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Hodgkin Disease × resminostat × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sezary Syndrome 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Hodgkin Disease 1

Interventions

Brentuximab Vedotin 21 pembrolizumab 11 Nivolumab 8 Vinblastine 6 Doxorubicin 6 Dacarbazine 6 plerixafor 4 fludarabine 4 Cyclophosphamide 4 Azacitidine 4 Melphalan 3 Granulocyte Colony-Stimulating Factor 3 Gemcitabine 3 Filgrastim 3 Etoposide 3 Busulfan 3 Bleomycin 3 pegfilgrastim 2 mocetinostat 2 givinostat hydrochloride 2 givinostat 2 fludarabine phosphate 2 cc-486 2 abexinostat 2 TPI-287 2 Rituximab 2 Panobinostat 2 Mycophenolic Acid 2 Leukapheresis 2 Dexamethasone 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01037478 2014-01-16

SAPHIRE

4SC AG

Phase 2 Completed

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡